Disease/Infection News

RSS

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Researchers investigated the role of the CD98 glycoprotein in inducing an inflammatory response to SARS-CoV-2 in patients of progressive fibrosis interstitial lung diseases, including the archetypal PFILD, idiopathic pulmonary fibrosis.

18 Aug 2022

Study highlights the lack of evidence-based clinical management guidelines for monkeypox

A dearth of high quality, up to date clinical guidance on monkeypox may be hampering effective and safe treatment of the infection around the world, concludes a review of what's available to guide patient care and published in the open access journal BMJ Global Health.

18 Aug 2022

Researchers investigate the acceptance of mandatory COVID-19 vaccination policy in Germany

It has become obvious that sufficiently high immunity to COVID-19 cannot be achieved in Germany through voluntary vaccination alone.

17 Aug 2022

An intervention approach to prevent infectious diseases in the future

Around three-quarters of emerging infectious diseases affecting humans are zoonotic, that is they emerge from wild and domestic animals.

17 Aug 2022

Eating disorders could be treated by modulating gut microbiota

Researchers describe how the gut-brain axis facilitates communication between the gastrointestinal tract and brain to regulate food consumption behaviors.

17 Aug 2022

Study detects asymptomatic monkeypox virus infection

A new study published in the Annals of Internal Medicine aimed to assess the presence of MPVX in the anorectal samples of MSM who had undergone routine tests for sexually transmitted infections from 5th June to 11th July 2022.

17 Aug 2022

Study links reduced myocardial blood flow and COVID-19

Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist.

17 Aug 2022

Acid ceramidase is a SARS-CoV-2 host factor, study says

Fluoxetine, a common antidepressant, inhibits the SARS-CoV-2 coronavirus in cell cultures and in preparations from human lung tissue. This was demonstrated by researchers at Julius-Maximilians-Universität (JMU) Würzburg in the summer of 2020. However, the mechanism of this inhibition was utterly unclear, so the teams continued their research.

17 Aug 2022

Study provides insights into understanding the biology of circulating Hepatitis E variants

Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are important for the virus in the course of its replication cycle and how it manages to maintain the infection.

17 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

The neutralizing antibody escape of BA.2.75 in mRNA-vaccinated and BA.1-infected individuals

Investigators analyzed the neutralization escape of the SARS-CoV-2 Omicron BA.2.75 variant.

17 Aug 2022

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Researchers demonstrated the relevance of the P681H spike mutation in the SARS-CoV-2 Alpha variant.

17 Aug 2022

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

17 Aug 2022

Disease/Infection News

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Study highlights the lack of evidence-based clinical management guidelines for monkeypox

Researchers investigate the acceptance of mandatory COVID-19 vaccination policy in Germany

An intervention approach to prevent infectious diseases in the future

Eating disorders could be treated by modulating gut microbiota

Study detects asymptomatic monkeypox virus infection

Study links reduced myocardial blood flow and COVID-19

Acid ceramidase is a SARS-CoV-2 host factor, study says

Study provides insights into understanding the biology of circulating Hepatitis E variants

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

The neutralizing antibody escape of BA.2.75 in mRNA-vaccinated and BA.1-infected individuals

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Genomic surveillance highlights the challenges posed by "shapeshifting" strains

Human-to-dog transmission of monkeypox virus reported

A dermatological approach to diagnosing monkeypox

Can evolutionary principles lead to new treatments or vaccines for monkeypox?

Understanding COVID aerosol dispersion from wind musical instruments

How useful is PCR for diagnosing monkeypox?

SARS-CoV-2 evolution within hosts and vaccination effects

Study estimates level of protection induced by booster doses of mRNA COVID-19 vaccine

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News